Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.14926562 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866902085598969856 |
|---|---|
| author | Dr. Ali Ameer Hamzah |
| author_facet | Dr. Ali Ameer Hamzah |
| contents | <p><span>The study analysed 110 patients undergoing dialysis and a control group between 2023 and 2024, representing 5% of all patients in Iraq. The data set included participants of both sexes and no age limit. The mean age of the patient cohort was 37.2 ± 3.2 years, while that of the control group was 36.9 ± 2.9 years. The objective of this study was to analyse the demographic data and information of Iraqi patients suffering from hyperparathyroidism among dialysis patients in different hospitals in Iraq. The statistical analysis program IBM SOFT SPSS 22 was employed to ascertain the true values and arithmetic means for all samples and laboratory results for patients. The findings of this study indicate that the patient cohort had a mean age of 37.2 ± 3.2 years, while that of the control group was 36.9 ± 2.9 years. The mean calcium level was 8.87±0.23 mg/dl in the patient group, while in the control group, 7.12±0.33 patients exhibited adequate calcium levels. The mean PO4 mg/dl in the blood of the patient group was 10.2±0.345 mg/dl, with a maximum. There were significant but non-significant differences in dialysis type and serum calcium. Statistically significant differences in compliance with target recommendations were found in the patient group, in addition to the occurrence of hypophosphatemia</span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_14926562 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Unveiling Hyperparathyroidism: Insights from Najaf's Dialysis Patients Dr. Ali Ameer Hamzah <p><span>The study analysed 110 patients undergoing dialysis and a control group between 2023 and 2024, representing 5% of all patients in Iraq. The data set included participants of both sexes and no age limit. The mean age of the patient cohort was 37.2 ± 3.2 years, while that of the control group was 36.9 ± 2.9 years. The objective of this study was to analyse the demographic data and information of Iraqi patients suffering from hyperparathyroidism among dialysis patients in different hospitals in Iraq. The statistical analysis program IBM SOFT SPSS 22 was employed to ascertain the true values and arithmetic means for all samples and laboratory results for patients. The findings of this study indicate that the patient cohort had a mean age of 37.2 ± 3.2 years, while that of the control group was 36.9 ± 2.9 years. The mean calcium level was 8.87±0.23 mg/dl in the patient group, while in the control group, 7.12±0.33 patients exhibited adequate calcium levels. The mean PO4 mg/dl in the blood of the patient group was 10.2±0.345 mg/dl, with a maximum. There were significant but non-significant differences in dialysis type and serum calcium. Statistically significant differences in compliance with target recommendations were found in the patient group, in addition to the occurrence of hypophosphatemia</span></p> |
| title | Unveiling Hyperparathyroidism: Insights from Najaf's Dialysis Patients |
| url | https://doi.org/10.5281/zenodo.14926562 |